Didier Cowling

Non-Executive Board Member & Co-Founder at Testmate Health

Didier Cowling has worked in the Biotech, Medtech, Pharma, Life Sciences, and Healthcare industries since 2018. In 2019, they became the Chairman of the Board for Hemotune AG, a medical device company based in Zürich, and a Non Executive Board Member for Terapet SA, a CERN start-up. Didier also became the Chairman of the Board for Volumina Medical, a spin-off of the EPFL founded in 2018, and a Non Executive Board Member for Plair SA, a company bringing unique solutions to address the needs for instantaneous and autonomous environmental monitoring. In 2020, they became a Non Executive Board Member for Artiria Medical, a Non-Executive Board Member and Co-Founder for Testmate Health, and an Entrepreneur In Residence for MassChallenge Switzerland. From 2016 to 2019, they were a Non Executive Board Member, President & Board Member, and CEO & Board Member for Kuros Biosciences, leading the merger of Kuros Biosurgery Holding AG into Cytos Biotechnology AG to form Kuros Biosciences AG, and subsequently leading the acquisition of Xpand Biotechnology BV.

Didier Cowling attended the University of Cambridge from 1984 to 1987, receiving an MA in Natural Sciences.

Links

Previous companies

Terapet logo
Plair SA logo


Teams

This person is not in any teams